GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Theratechnologies Inc (NAS:THTX) » Definitions » Institutional Ownership

Theratechnologies (Theratechnologies) Institutional Ownership : 0.06% (As of Jun. 09, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Theratechnologies Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Theratechnologies's institutional ownership is 0.06%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Theratechnologies's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Theratechnologies's Float Percentage Of Total Shares Outstanding is 99.61%.


Theratechnologies Institutional Ownership Historical Data

The historical data trend for Theratechnologies's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Theratechnologies Institutional Ownership Chart

Theratechnologies Historical Data

The historical data trend for Theratechnologies can be seen below:

2023-08-31 2023-09-30 2023-10-31 2023-11-30 2023-12-31 2024-01-31 2024-02-29 2024-03-31 2024-04-30 2024-05-31
Institutional Ownership 0.94 0.94 0.49 0.49 0.05 0.06 0.06 0.06 0.06 0.06

Theratechnologies Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Theratechnologies (Theratechnologies) Business Description

Traded in Other Exchanges
Address
2015, rue Peel, 11e etage, Montreal, QC, CAN, H3A 1T8
Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States.